|
Metkinen Oy specializes in mutagenic treatment and methods of screening for high productive mutants of fungal and bacterial producers, particularly in cholesterol lowering agents (statins) and antibiotics. We offer contractual strain development or improvement, fermentation and downstream processing technologies. Metkinen Oy is Finnish company specialized in technology transfer and marketing in areas of biomedicine, biotechnology and pharmacology. For the last 3 years Metkinen Oy specialized in anti-sclerotic compounds and natural cardiovascular (lipid-lowering) agents - statins such as lovastatin, compactin, pravastatin. Several of our research projects have been dealing with investigation of effective technologies of isolation and purification of HMG-CoA reductase inhibitors (statins).
Activity:
- Licensing & Business Development
- Manufacturing
- Market Research & Marketing
Product / Technology type(s) covered:
- API / chemicals
- Bio
- Nutritionals / Vitamins
- Technology
Therapeutic targets:
- Cardiovascular
|
|